On the Path to Production: BioVax Board Inspects Progress at Embakasi Facility
The Chairman of the Board of Directors, Dr. Charles Githinji, led members of the Kenya BioVax Institute Limited Board on an inspection visit to the Embakasi manufacturing site to assess the ongoing enabling works and overall project progress. Accompanied by...
Harnessing Private Sector Efficiency in Vaccine Manufacturing
Kenya BioVax Institute Limited hosted a Workshop on Chartering the Roadmap to the First Vial, bringing together leadership, partners, and experts driving Kenya’s vaccine manufacturing agenda. Keynote Speaker Mr. Joe Sang, EBS, Managing Director – Kenya Pipeline Company Limited, delivered...
Government and Partners Rally Behind BioVax to Accelerate Kenya’s Vaccine Agenda
Kenya BioVax Institute Limited appreciates the continued commitment of the Government of Kenya, through the MOH_Kenya, to advancing local vaccine research, development, and manufacturing as a key pillar of health security and Universal Health Coverage (UHC). We were honoured to...
Kenya BioVax Mission to Korea Strengthens Path to Vaccine Self-Reliance
The Kenya Bio-Vaccine Mission Program in the Republic of Korea (23rd–30th October 2025) brought together Kenyan experts and institutions, including the Kenya BioVax Institute Limited, to benchmark Korea’s world-class vaccine research, manufacturing, and innovation ecosystem. Through visits to Celltrion Inc,...
